![Christopher Rovaldi](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Christopher Rovaldi
No open positions remaining
Profile
Christopher Rovaldi is SVP-Program Management & Operations at Acceleron Pharma, Inc. Mr. Rovaldi previously held the position of Director-Project Management at Idenix Pharmaceuticals LLC, Senior Research Associate of Periodontix, Inc. and Director-Project Management at Cubist Pharmaceuticals LLC. He received a graduate degree and an undergraduate degree from the University of New Hampshire.
Former positions of Christopher Rovaldi
| Companies | Position | End |
|---|---|---|
| KEROS THERAPEUTICS, INC. | President | 17/08/2025 |
| ACCELERON PHARMA INC. | Chief Operating Officer | 30/04/2018 |
| IDENIX PHARMACEUTICALS INC | Corporate Officer/Principal | 31/12/2006 |
| CUBIST PHARMACEUTICALS INC | Corporate Officer/Principal | 31/12/2003 |
Periodontix, Inc.
 Periodontix, Inc. Miscellaneous Commercial ServicesCommercial Services Provides research and development in the biopharmaceutical industry; develops next generation antimicrobial agents for the prevention and treatment of each stage of periodontal disease | Corporate Officer/Principal | - |
Training of Christopher Rovaldi
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
57
1st degree connections
6
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
Cubist Pharmaceuticals LLC
 Cubist Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Engages in research, development and commercialization of pharmaceutical products | Health Technology |
Idenix Pharmaceuticals LLC
 Idenix Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops drugs for the treatment of human viral and infectious diseases caused by hepatitis | Health Technology |
Acceleron Pharma, Inc.
 Acceleron Pharma, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company which develops protein therapeutics for cancer and orphan diseases | Health Technology |
Periodontix, Inc.
Periodontix, Inc. Miscellaneous Commercial ServicesCommercial Services Provides research and development in the biopharmaceutical industry; develops next generation antimicrobial agents for the prevention and treatment of each stage of periodontal disease | Commercial Services |
University of New Hampshire
 University of New Hampshire Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Keros Therapeutics, Inc.
 Keros Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops therapeutics for muscle diseases | Health Technology |
- Stock Market
- Insiders
- Christopher Rovaldi
Choose MarketScreener 
